ADVERSE EVENTS AND PATTERNS OF TUMOR PROGRESSION IN MET DIAGNOSTIC SUBGROUPS IN OAM4558G; A PHASE II STUDY EVALUATING METMAB OR PLACEBO IN COMBINATION WITH ERLOTINIB IN ADVANCED NSCLC Conference

Vashishtha, Anshu, Patel, Premal, Yu, Wei et al. (2011). ADVERSE EVENTS AND PATTERNS OF TUMOR PROGRESSION IN MET DIAGNOSTIC SUBGROUPS IN OAM4558G; A PHASE II STUDY EVALUATING METMAB OR PLACEBO IN COMBINATION WITH ERLOTINIB IN ADVANCED NSCLC . JOURNAL OF THORACIC ONCOLOGY, 6(6), S1276-S1277.

International Collaboration

cited authors

  • Vashishtha, Anshu; Patel, Premal; Yu, Wei; Bothos, John; Simpson, Joe; Maneatis, Thomas; Doessegger, Lucette; Peterson, Amy; Clement-Duchene, Christelle; Robinet, Gilles; Krzakowski, Maciej; Blumenschein, George; Goldschmidt, Jerome; Daniel, Davey B; Ramlau, Rodryg; Ervin, Thomas; Spigel, David

authors

publication date

  • June 1, 2011

published in

keywords

  • Life Sciences & Biomedicine
  • MetMAb
  • NSCLC
  • Oncology
  • Respiratory System
  • Science & Technology
  • cMet
  • erlotinib

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • S1276

end page

  • S1277

volume

  • 6

issue

  • 6